Lenalidomide in cancer cachexia: a randomized trial of an anticancer drug applied for anti‐cachexia

• Main Authors: David Blum (Author), Caroline Hertler (Author), Rolf Oberholzer (Author), Susanne deWolf‐Linder (Author), Markus Joerger (Author), Christoph Driessen (Author), Florian Strasser (Author)
• Format: Book
• Published: Wiley, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Cancer cachexia (CC) impacts quality of life, physical function, anticancer treatment response, and survival. Inflammation is a prominent pathomechanism of CC. This small‐scale study sets out to investigate the immunomodulatory drug lenalidomide in inflammatory CC in a randomized...